Paid Clinical Trials in Gulfport, MS
As of June 2026, 31 paid clinical trials are recruiting in Gulfport, Mississippi. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Gulfport offers studies at sites including Gulfport Memorial Hospital for conditions such as Anatomic Stage IV Breast Cancer AJCC v8, Graves' Disease, Hypertension, Obesity. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Gulfport
Trials by drug in Gulfport
Filter results
31 clinical trials
↓ Download CSVA Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
A Registry Based Collaborative to Measure Efficiency, Effectiveness, and Safety of Farapulse PFA Technology for AF
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Mobile Health for Adherence in Breast Cancer Patients
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
STRIVE Post-Market Registry Study
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Patient Retrospective Outcomes (PRO)
About research studies in Gulfport
Gulfport has approximately 31 recruiting research studies across a wide range of therapeutic areas. Mississippi hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Gulfport
Researchers run research studies in Gulfport, MS at 15 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Gulfport Memorial Hospital | Anatomic Stage IV Breast Cancer AJCC v8, Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8 | 11 |
| Memorial Hospital at Gulfport | Emphysema, Interstitial Lung Disease, Lung Cancer Diagnosis | 4 |
| DelRicht Clinical Research - Gulfport | Chronic Idiopathic Constipation (CIC) | 1 |
| DelRicht Research | Influenza | 1 |
| DelRicht Research Gulfport | Acute Gout Flare, Acute Gouty Arthritis, Gout Flare | 1 |
| DelRicht Research-Gulfport | COVID-19 | 1 |
| Dynamed Clinical Research, LP d/b/a DM Clinical Research | Obesity, Overweight | 1 |
| MedPharmics, LLC | Obesity, Overweight | 1 |
| Memorial Hospital Gulfport | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 1 |
| NeuroSpecs-Gulfport Performance Spine | Chronic Pain | 1 |
| Singing River Gulfport | Lumbar Spinal Stenosis | 1 |
| The Heart Rhythm Center of Mississippi | Atrial Fibrillation | 1 |
| Velocity Clinical Research | SARS-CoV-2 | 1 |
| Velocity Clinical Research - Gulfport | Diabetic Peripheral Neuropathic Pain | 1 |
| Velocity Clinical Research, Gulfport | RSV Infection | 1 |
Active & Upcoming Studies in Gulfport (2026)
Recruiting trials in Gulfport grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (11 active studies)
- Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial) · Phase 2, Phase 3 · SWOG Cancer Research Network
- A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma · Phase 2 · Loxo Oncology, Inc.
Vaccines (4 active studies)
- A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza · Phase 3 · Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations · Phase 4 · ModernaTX, Inc.
Cardiovascular (4 active studies)
- Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest · Phase 3 · Invero Pharma, Inc.
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
Diabetes & metabolic (3 active studies)
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
- A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) · Phase 3 · Eli Lilly and Company
Neurology & pain (2 active studies)
- Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy · Phase 3 · Vertex Pharmaceuticals Incorporated
- Patient Retrospective Outcomes (PRO) · Boston Scientific Corporation
Common conditions studied in Gulfport
- Anatomic Stage IV Breast Cancer AJCC v8 (3 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Graves' Disease (2 active studies). Recruiting Graves' Disease studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Hypertension (2 active studies). Hypertension research tests new antihypertensive drug classes, renal denervation devices, and fixed-dose combinations for resistant disease.
- Obesity (2 active studies). Obesity trials evaluate GLP-1 and GIP receptor agonists, novel metabolic drugs, and combined lifestyle interventions for sustainable weight loss.
- Overweight (2 active studies). Recruiting Overweight studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Acute Gout Flare (1 active study). Recruiting Acute Gout Flare studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Gulfport
- SWOG Cancer Research Network
- ECOG-ACRIN Cancer Research Group
- Eli Lilly and Company
- Immunovant Sciences GmbH
- ModernaTX, Inc.
Local regulations and guidelines
Clinical trials in Mississippi are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Mississippi research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Gulfport. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Gulfport
Hipa.ai aggregates every recruiting study in Gulfport from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Gulfport?
There are approximately 31 recruiting clinical trials in Gulfport, Mississippi listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Gulfport pay participants?
Most recruiting trials in Gulfport compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Gulfport?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Gulfport?
The most common conditions under active study in Gulfport include Anatomic Stage IV Breast Cancer AJCC v8 (3), Graves' Disease (2), Hypertension (2), Obesity (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Gulfport?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Gulfport on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Gulfport?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Gulfport?
Recruiting research sites in Gulfport include Gulfport Memorial Hospital, Memorial Hospital at Gulfport, DelRicht Clinical Research - Gulfport, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Gulfport right now?
The largest active categories in Gulfport are Cancer & tumors (11), Vaccines (4), Cardiovascular (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.